The current disclosure relates to technology for predicting cardiotoxicity of compounds. In vitro methods using human stem-cell derived cardiomyocytes cultured in specific media are disclosed, as well as kits for use in the method. In the method, the cells are treated with a test compound in combination with a mitochondrial toxicant.
本公开涉及预测化合物心脏毒性的技术。公开了使用在特定
培养基中培养的人类干细胞衍生心肌细胞的体外方法,以及用于该方法的试剂盒。在该方法中,细胞将与线粒体毒性物质结合使用一种测试化合物进行处理。